Lipid metabolism of plasma-derived small extracellular vesicles in COVID-19 convalescent patients.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
03 10 2023
03 10 2023
Historique:
received:
21
04
2023
accepted:
20
09
2023
medline:
5
10
2023
pubmed:
4
10
2023
entrez:
3
10
2023
Statut:
epublish
Résumé
The coronavirus disease 2019 (COVID-19), which affects multiple organs, is causing an unprecedented global public health crisis. Most COVID-19 patients recover gradually upon appropriate interventions. Viruses were reported to utilize the small extracellular vesicles (sEVs), containing a cell-specific cargo of proteins, lipids, and nucleic acids, to escape the attack from the host's immune system. This study aimed to examine the sEVs lipid profile of plasma of recovered COVID-19 patients (RCs). Plasma sEVs were separated from 83 RCs 3 months after discharge without underlying diseases, including 18 recovered asymptomatic patients (RAs), 32 recovered moderate patients (RMs), and 33 recovered severe and critical patients (RSs), and 19 healthy controls (HCs) by Total Exosome Isolation Kit. Lipids were extracted from sEVs and then subjected to targeted liquid chromatography-mass spectrometry. The size, concentration, and distribution of sEVs did not differ in RCs and HCs as validated by transmission electron microscopy, nanoparticle tracking analysis, and immunoblot analysis. Fifteen subclasses of 508 lipids were detected in plasma sEVs from HCs, RAs, RMs, and RSs, such as phosphatidylcholines (PCs) and diacylglycerols (DAGs), etc. Total lipid intensity displayed downregulation in RCs compared with HCs. The relative abundance of DAGs gradually dropped, whereas PCs, lysophosphatidylcholines, and sphingomyelins were higher in RCs relative to HCs, especially in RSs. 88 lipids out of 241 in sEVs of RCs were significantly different and a conspicuous increase was revealed with disease status. The sEVs lipids alternations were found to be significantly correlated with the clinical indices in RCs and HCs, suggesting that the impact of COVID-19 on lipid metabolism lingered for a long time. The lipid abnormalities bore an intimate link with glycerophospholipid metabolism and glycosylphosphatidylinositol anchor biosynthesis. Furthermore, the lipidomic analysis showed that RCs were at higher risk of developing diabetes and sustaining hepatic impairment. The abnormality of immunomodulation in RCs might still exist. The study may offer new insights into the mechanism of organ dysfunction and help identify novel therapeutic targets in the RCs.
Identifiants
pubmed: 37789017
doi: 10.1038/s41598-023-43189-5
pii: 10.1038/s41598-023-43189-5
pmc: PMC10547714
doi:
Substances chimiques
Diglycerides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16642Informations de copyright
© 2023. Springer Nature Limited.
Références
Pagnesi, M., Adamo, M. & Metra, M. March 2021 at a glance: Focus on epidemiology, prevention and COVID-19. Eur. J. Heart Fail. 23, 347–349 (2021).
pubmed: 33915003
Gupta, A. et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 26, 1017–1032 (2020).
pubmed: 32651579
Schellhorn, P., Klingel, K. & Burgstahler, C. Return to sports after COVID-19 infection. Eur. Heart J. 41, 4382–4384 (2020).
pubmed: 32432700
Fang, Y., Zhou, J., Ding, X., Ling, G. & Yu, S. Pulmonary fibrosis in critical ill patients recovered from COVID-19 pneumonia: Preliminary experience. Am. J. Emerg. Med. 38, 2134–2138 (2020).
pubmed: 33071084
pmcid: 7368908
Huang, L. et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc. Imaging 13, 2330–2339 (2020).
pubmed: 32763118
pmcid: 7214335
Puntmann, V. O. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5, 1265–1273 (2020).
pubmed: 32730619
pmcid: 7385689
Anderson, M. R., Kashanchi, F. & Jacobson, S. Exosomes in viral disease. Neurotherapeutics 13, 535–546 (2016).
pubmed: 27324390
pmcid: 4965413
Horn, M. D. & MacLean, A. G. Extracellular vesicles as a means of viral immune evasion, CNS invasion, and glia-induced neurodegeneration. Front. Cell Neurosci. 15, 695899 (2021).
pubmed: 34290592
pmcid: 8287503
Meldolesi, J. Exosomes and ectosomes in intercellular communication. Curr. Biol. 28, R435-r444 (2018).
pubmed: 29689228
Gurunathan, S., Kang, M. H., Jeyaraj, M., Qasim, M. & Kim, J. H. Correction: Gurunathan, S. et al. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells 2019, 8, 307. Cells 10, 462 (2021).
pubmed: 33671844
pmcid: 7926903
Hassanpour, M., Rezaie, J., Nouri, M. & Panahi, Y. The role of extracellular vesicles in COVID-19 virus infection. Infect. Genet. Evol. 85, 104422 (2020).
pubmed: 32544615
pmcid: 7293471
Arenaccio, C. et al. Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1. Retrovirology 12, 87 (2015).
pubmed: 26502902
pmcid: 4623921
Barberis, E. et al. Circulating exosomes are strongly involved in SARS-CoV-2 infection. Front. Mol. Biosci. 8, 632290 (2021).
pubmed: 33693030
pmcid: 7937875
Zhang, C. et al. Lipidomic profiling of virus infection identifies mediators that resolve herpes simplex virus-induced corneal inflammatory lesions. Analyst 145, 3967–3976 (2020).
pubmed: 32319474
Leaptrot, K. L., May, J. C., Dodds, J. N. & McLean, J. A. Ion mobility conformational lipid atlas for high confidence lipidomics. Nat. Commun. 10, 985 (2019).
pubmed: 30816114
pmcid: 6395675
Christie, W. W. The composition, structure and function of lipids in the tissues of ruminant animals. Prog. Lipid Res. 17, 111–205 (1978).
pubmed: 390540
Hadley, N. F. Integumental lipids of plants and animals: Comparative function and biochemistry. Adv Lipid Res 24, 303–320 (1991).
pubmed: 1763716
Abu-Farha, M. et al. The role of lipid metabolism in COVID-19 virus infection and as a drug target. Int. J. Mol. Sci. 21, 3544 (2020).
pubmed: 32429572
pmcid: 7278986
Wu, Q. et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci. Rep. 7, 9110 (2017).
pubmed: 28831119
pmcid: 5567209
Kyle, J. E. et al. Plasma lipidome reveals critical illness and recovery from human Ebola virus disease. Proc. Natl. Acad. Sci. U.S.A. 116, 3919–3928 (2019).
pubmed: 30808769
pmcid: 6397561
Nguyen, A. et al. Host lipidome analysis during rhinovirus replication in HBECs identifies potential therapeutic targets. J. Lipid Res. 59, 1671–1684 (2018).
pubmed: 29946055
pmcid: 6121942
Wu, D. et al. Plasma metabolomic and lipidomic alterations associated with COVID-19. Natl. Sci. Rev. 7, 1157–1168 (2020).
pubmed: 34676128
pmcid: 7197563
Lam, S. M. et al. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat Metab 3, 909–922 (2021).
pubmed: 34158670
Xu, J. et al. Plasma metabolomic profiling of patients recovered from coronavirus disease 2019 (COVID-19) with pulmonary sequelae 3 months after discharge. Clin. Infect. Dis. 73, 2228–2239 (2021).
pubmed: 33596592
pmcid: 7929060
Smilowitz, N. R. et al. C-reactive protein and clinical outcomes in patients with COVID-19. Eur. Heart J. 42, 2270–2279 (2021).
pubmed: 33448289
pmcid: 7928982
Sahu, B. R., Kampa, R. K., Padhi, A. & Panda, A. K. C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection. Clin. Chim. Acta 509, 91–94 (2020).
pubmed: 32511972
pmcid: 7274122
Martín-Acebes, M. A. et al. Host sphingomyelin increases West Nile virus infection in vivo. J. Lipid Res. 57, 422–432 (2016).
pubmed: 26764042
pmcid: 4766991
Bursten, S. L. et al. An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome. Crit. Care Med. 24, 1129–1136 (1996).
pubmed: 8674324
An, T. et al. Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. J. Extracell. Vesicles 4, 27522 (2015).
pubmed: 26095380
Zhang, Y., Liu, Y., Liu, H. & Tang, W. H. Exosomes: Biogenesis, biologic function and clinical potential. Cell Biosci. 9, 19 (2019).
pubmed: 30815248
pmcid: 6377728
Song, J. W. et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 32, 188-202.e185 (2020).
pubmed: 32610096
pmcid: 7311890
Urbanelli, L. et al. The role of extracellular vesicles in viral infection and transmission. Vaccines 7, 102 (2019).
pubmed: 31466253
pmcid: 6789493
Subra, C. et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res 51, 2105–2120 (2010).
pubmed: 20424270
pmcid: 2903822
Wu, D. et al. Plasma metabolomic and lipidomic alterations associated with COVID-19. Natl. Sci. Rev. 7, 1157–1168 (2020).
pubmed: 34676128
pmcid: 7197563
Hao, Y. et al. Distinct lipid metabolic dysregulation in asymptomatic COVID-19. iScience 24, 102974 (2021).
pubmed: 34396083
pmcid: 8356725
Ciccarelli, M. et al. Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy). J. Pharm. Biomed. Anal. 217, 114827 (2022).
pubmed: 35569273
pmcid: 9085356
van der Veen, J. N. et al. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim. Biophys. Acta 1859, 1558–1572 (2017).
Luo, P. et al. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma. Hepatology 67, 662–675 (2018).
pubmed: 28960374
Zhang, J. et al. Positive-strand RNA viruses stimulate host phosphatidylcholine synthesis at viral replication sites. Proc. Natl. Acad. Sci. U S A 113, E1064-1073 (2016).
pubmed: 26858414
pmcid: 4776486
Hofmann, S. et al. Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication. Biochim. Biophys. Acta 1863, 1041–1056 (2018).
Sanchez-Lopez, E. et al. Choline uptake and metabolism modulate macrophage IL-1β and IL-18 production. Cell Metab. 29, 1350-1362.e1357 (2019).
pubmed: 30982734
pmcid: 6675591
Zhang, S. et al. Plasma metabolomic profiles in recovered COVID-19 patients without previous underlying diseases 3 months after discharge. J. Inflamm. Res. 14, 4485–4501 (2021).
pubmed: 34522117
pmcid: 8434912
Massart, J. & Zierath, J. R. Role of diacylglycerol kinases in glucose and energy homeostasis. Trends Endocrinol. Metab. 30, 603–617 (2019).
pubmed: 31331711
Wang, S. et al. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: A multi-centre retrospective study. Diabetologia 63, 2102–2111 (2020).
pubmed: 32647915
pmcid: 7347402
Meininger, G. et al. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution. Metabolism 51, 260–266 (2002).
pubmed: 11833059
Bowman, E. R. et al. Altered lipidome composition is related to markers of monocyte and immune activation in antiretroviral therapy treated human immunodeficiency virus (HIV) infection and in uninfected persons. Front. Immunol. 10, 785 (2019).
pubmed: 31040846
pmcid: 6477036
Cmielewski, P., Anson, D. S. & Parsons, D. W. Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: Effect of acyl chain length. Respir. Res. 11, 84 (2010).
pubmed: 20569421
pmcid: 2905357
Zhou, M. et al. Adenovector-mediated gene transfer of lysophosphatidylcholine acyltransferase 1 attenuates oleic acid-induced acute lung injury in rats. Crit. Care Med. 42, e716-724 (2014).
pubmed: 25319916
Gardinassi, L. G., Souza, C. O. S., Sales-Campos, H. & Fonseca, S. G. Immune and metabolic signatures of COVID-19 revealed by transcriptomics data reuse. Front. Immunol. 11, 1636 (2020).
pubmed: 32670298
pmcid: 7332781
Shen, B. et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59–72 (2020).
pubmed: 32492406
pmcid: 7254001
Tian, Y. et al. Protein profiling and sizing of extracellular vesicles from colorectal cancer patients via flow cytometry. ACS Nano 12, 671–680 (2018).
pubmed: 29300458
Sundar, I. K., Li, D. & Rahman, I. Small RNA-sequence analysis of plasma-derived extracellular vesicle miRNAs in smokers and patients with chronic obstructive pulmonary disease as circulating biomarkers. J. Extracell. Vesicles 8, 1684816 (2019).
pubmed: 31762962
pmcid: 6848892
Xiong, Y. H. et al. Comparison of methods of isolating extracellular vesicle microRNA from HepG2 cells for High-throughput sequencing. Front. Mol. Biosci. 9, 976528 (2022).
pubmed: 36225253
pmcid: 9549333
Lydic, T. A. et al. Rapid and comprehensive “shotgun” lipidome profiling of colorectal cancer cell derived exosomes. Methods 87, 83–95 (2015).
pubmed: 25907253
pmcid: 4615275
Lydic, T. A., Busik, J. V. & Reid, G. E. A monophasic extraction strategy for the simultaneous lipidome analysis of polar and nonpolar retina lipids. J. Lipid Res. 55, 1797–1809 (2014).
pubmed: 24879804
pmcid: 4109773
Zhang, H. et al. Optimization of lipid extraction and analytical protocols for UHPLC-ESI-HRMS-based lipidomic analysis of adherent mammalian cancer cells. Anal. Bioanal. Chem. 409, 5349–5358 (2017).
pubmed: 28717896